Still, I don’t know whether the rules are as stringent and the costs as high all over the world, nor whether a non-profit which had researchers with excellent credentials would be unable to raise that much money.
If rules were relaxed or costs were lower somewhere else, then wouldn’t for-profit drug development move there as well? Whatever the funding model, the actual research and laws that govern it are the same.
I was underestimating the size of the problem.
Still, I don’t know whether the rules are as stringent and the costs as high all over the world, nor whether a non-profit which had researchers with excellent credentials would be unable to raise that much money.
If rules were relaxed or costs were lower somewhere else, then wouldn’t for-profit drug development move there as well? Whatever the funding model, the actual research and laws that govern it are the same.